Illumina's preliminary Q4 revenue and adjusted EPS exceed expectations
Show original
By:格隆汇
Gelonghui January 14th|Gene sequencing solutions company Illumina announced its preliminary results for the fourth quarter, with revenue reaching $1.155 billion, up 5% year-on-year and exceeding analysts' expectations of $1.1 billion. Adjusted earnings per share were between $1.27 and $1.3, also above the expected $1.21. The company has partnered with pharmaceutical companies such as AstraZeneca, Merck, and Eli Lilly to launch the world's largest whole-genome genetic perturbation dataset to accelerate AI-driven drug discovery.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Why Molson Coors (TAP) Stock Is Dropping Today
101 finance•2026/01/16 21:36
Why Shares of Sirius XM (SIRI) Are Falling Today
101 finance•2026/01/16 21:36
Why Shares of PNC Financial Services Group (PNC) Are Rising Today
101 finance•2026/01/16 21:36
Why Trimble (TRMB) Stock Is Dropping Sharply Today
101 finance•2026/01/16 21:36
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$95,294.8
-0.21%
Ethereum
ETH
$3,285.96
-0.38%
Tether USDt
USDT
$0.9995
-0.02%
BNB
BNB
$934.28
+0.45%
XRP
XRP
$2.07
-0.01%
Solana
SOL
$144.91
+1.91%
USDC
USDC
$0.9997
-0.00%
TRON
TRX
$0.3104
-0.49%
Dogecoin
DOGE
$0.1377
-1.46%
Cardano
ADA
$0.3960
+0.74%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now